Laboratory Automation: Communications with Automated Clinical Laboratory Systems, Instruments, Devices, and Information Systems (AUTO3-A2)
Detection of HLA-Specific Alloantibody by Flow Cytometry and Solid Phase Assays (I/LA29-P)
Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi (M38-A2)

CLSI submits the following for vote as a candidate-for-advancement consensus documents.  The documents and ballots are available to delegates and alternates of Active and Associate Active member organizations through CLSI Forums. 

I/LA29-P— Detection of HLA-Specific Alloantibody by Flow Cytometry and Solid Phase Assays; Proposed Guideline
This guideline will describe criteria for optimizing methods that utilize flow cytometry and other conventional and multiplex platforms. The deadline for the completed ballot for I/LA29-P to be received at the CLSI offices is 15 February 2008.

Second Notice

AUTO3-A2—Laboratory Automation: Communications with Automated Clinical Laboratory Systems, Instruments, Devices, and Information Systems; Approved Standard—Second Edition
This document provides standards to facilitate accurate and timely electronic exchange of data and information between the automated laboratory elements. The deadline for the completed ballot for AUTO3-A2 to be received at the CLSI offices is 11 January 2008.

M38-A2—Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi; Approved Standard—Second Edition
This document addresses the selection of antifungal agents; preparation of antifungal stock solutions and dilutions for testing; implementation and interpretation of test procedures; and quality control requirements for susceptibility testing of filamentous fungi (moulds) that cause invasive fungal infections. The deadline for the completed ballot for M38-A2 to be received at the CLSI offices is 4 January 2008.

Under our Administrative Procedures, a CLSI document approved by the area committee at the first level of the consensus process is submitted to delegates as a “candidate-for-advancement” consensus document. This begins the voting and approval period by the delegates.

As a delegate, your vote is to affirm (or reject) the document for advancement as a CLSI document. Please send your completed ballot to the CLSI offices by the above deadline.

In the consensus process, comments are invited at each publication stage. In each edition, the responsible committee includes a summary of comments on the prior edition and its responses to them. Any comments received on a candidate-for-advancement consensus document as a result of delegate voting and consensus review will be addressed by the committee during the document’s advancement.

Find out more about Active and Associate Active membership.

[ return to top ]